Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
High-Resolution HLA Typing for Sensitized Patients: Advances in Medicine and Science Require Us to Challenge Existing Paradigms.
Development of a PET radioligand for potassium channels to image CNS demyelination.
Screening for Lung Cancer: Incidental Pulmonary Parenchymal Findings.
Critique of Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation trial.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Critique of Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation trial.
Critique of Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation trial. Stroke. 2014 Jul; 45(7):2151-3.
View in:
PubMed
subject areas
Adult
Atrial Fibrillation
Dose-Response Relationship, Drug
Double-Blind Method
Factor Xa Inhibitors
Humans
Pyridines
Randomized Controlled Trials as Topic
Stroke
Thiazoles
Treatment Outcome
Warfarin
authors with profiles
Shyam Prabhakaran